<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04918498</url>
  </required_header>
  <id_info>
    <org_study_id>2021-0205</org_study_id>
    <nct_id>NCT04918498</nct_id>
  </id_info>
  <brief_title>Application of Early Physical Therapy Regimens in Patients With Veno-venos Extracorporeal Membrane Oxygenation</brief_title>
  <acronym>VV-ECMO</acronym>
  <official_title>Application of Early Physical Therapy Regimens in Patients With Veno-venos Extracorporeal Membrane Oxygenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jiaxing Second Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yuhang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changxing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Promote early recovery through the application of early physiotherapy programs for VV-ECMO&#xD;
      patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is intended to construct early physiotherapy programs for VV-ECMO patients,&#xD;
      including multidisciplinary team building, safety assessment, early active physiotherapy,&#xD;
      respiratory physiotherapy, with a view to promoting early recovery of patients, early&#xD;
      withdrawal of ventilator-assisted ventilation, shortening ECMO auxiliary time, improving&#xD;
      patients' exercise level and respiratory function, reducing complications, and improving the&#xD;
      quality of near-term and long-term survival.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Non-contemporaneous control</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VV-ECMO auxiliary time</measure>
    <time_frame>1 year</time_frame>
    <description>the time for VV-ECMO auxiliary</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Extracorporeal Membrane Oxygenation Complication</condition>
  <arm_group>
    <arm_group_label>routine treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Review the collection of patient-related clinical data, collation of clinical data and outcome indicators</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implement early physiotherapy programs. The early physiotherapy program for VV-ECMO patients mainly includes the establishment of multidisciplinary teams, safety assessment, early activity physiotherapy and respiratory physiotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>early physiotherapy programs</intervention_name>
    <description>establishment of multidisciplinary teams, safety assessment, early activity physiotherapy and respiratory physiotherapy</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>routine treatment</intervention_name>
    <description>provide routine nursing and rehabilitation program</description>
    <arm_group_label>routine treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  VV-ECMO assisted support&#xD;
&#xD;
          -  lung failure (e.g. ARDS)&#xD;
&#xD;
          -  age â‰¥18 years&#xD;
&#xD;
          -  sober&#xD;
&#xD;
          -  informed consent to this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unstable blood flow mechanics&#xD;
&#xD;
          -  active bleeding&#xD;
&#xD;
          -  mental disorders that do not work together&#xD;
&#xD;
          -  people waiting for lung transplants&#xD;
&#xD;
          -  people at the end of life (e.g. advanced lung cancer)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fei Zeng</last_name>
    <role>Study Chair</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fei Zeng</last_name>
    <phone>13757119536</phone>
    <email>zengfei@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>SAHZhejiangU</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Zeng</last_name>
      <phone>13757119536</phone>
      <email>zengfei@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

